About
The Chemistry Laboratory is a joint unit operated by the CNRS, the École Normale Supérieure of Lyon and Université Lyon 1.
The Chemistry Laboratory spans a range of specialities in chemistry and physical chemistry It develops interdisciplinary research projects at the frontiers with biology, material sciences and physics.
- Three research axis
-
Theoretical Chemistry & Molecular ThermodynamicsThe team is a THEORY and MODELLING group spanning different lenght scales from atomic-scale, nano-scale to meso-scale. Read more
-
Supramolecular Chemistry and Chemical BiologyConfinement, encapsulation, self-assembly and switchable (supra)molecular systems, bioimaging and understanding of biological mechanisms are representative of the research activities of our research group. Read more
-
Molecules and Nanomaterials for OpticsOur objective is to develop high-level multidisciplinary research activities based on the design, characterisation and applications of molecules and materials with advanced optical and photonic properties, using state-of-the-art (...) Read more
- Press releases
-
May 22, 2026 When research and industry jointly invent the materials for the transition
-
May 17, 2026 Congratulations to Dr. Mathilde Seinfeld and Dr. Yoann Freroux for winning the PhD Thesis Prize in Photochemistry, Photophysics, and Photosciences at Photonano26!
-
Mar 10, 2026 The LCH, as part of a consortium of European scientists, has developed a new molecular tool that both promotes the formation of protein crystals and makes them immediately visible through fluorescence. This approach could simplify and accelerate access to their three-dimensional structures, which are essential for understanding life and developing new therapies
-
Feb 23, 2026 The current management of tumors relies on a series of steps: diagnosis, treatment, and check-up. These steps are distributed across multiple hospital departments and complicate cancer treatment. The European project Scan Nano Treat, coordinated by Université Claude Bernard Lyon 1 and funded by the European Innovation Council (EIC) Transition, aims to transform this model through “all-in-one” nanoparticles that combine cancer imaging and treatment. At the intersection of chemistry, medical imaging, and innovation, this project opens major perspectives for both medicine and industrial transfer.
- Agenda
-
Oct 22, 2026 9:30 AM to 11:30 AM - André Collet
-
Oct 29, 2026 Boroxine-based cages and macrocycles and their dynamic behavior
-
Nov 02, 2026 Design d'électrolytes pour batteries à ions divalents
-
Nov 03, 2026 When Molecular Motion Controls Luminescence in Rotaxanes and Catenanes


